NDC 43598-345

Imatinib

Imatinib

Imatinib is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dr.reddy's Laboratories Inc. The primary component is Imatinib Mesylate.

Product ID43598-345_01fcd1cf-5e84-3f2e-d15d-6ba745f4baf9
NDC43598-345
Product TypeHuman Prescription Drug
Proprietary NameImatinib
Generic NameImatinib
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-08-13
Marketing CategoryANDA / ANDA
Application NumberANDA206547
Labeler NameDr.Reddy's Laboratories Inc
Substance NameIMATINIB MESYLATE
Active Ingredient Strength400 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 43598-345-05

500 TABLET in 1 CONTAINER (43598-345-05)
Marketing Start Date2018-08-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43598-345-30 [43598034530]

Imatinib TABLET
Marketing CategoryANDA
Application NumberANDA206547
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-13

NDC 43598-345-90 [43598034590]

Imatinib TABLET
Marketing CategoryANDA
Application NumberANDA206547
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-13

NDC 43598-345-05 [43598034505]

Imatinib TABLET
Marketing CategoryANDA
Application NumberANDA206547
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-13

Drug Details

Active Ingredients

IngredientStrength
IMATINIB MESYLATE400 mg/1

OpenFDA Data

SPL SET ID:559dd8e5-11f9-70cd-3fb0-9f9eb8484a37
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 403878
  • 403879

    • Pharmacological Class

    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]
    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    43598034530 IMATINIB MESYLATE 400 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Imatinib" or generic name "Imatinib"

    NDCBrand NameGeneric Name
    43598-344ImatinibImatinib
    43598-345ImatinibImatinib
    0378-2245Imatinib Mesylateimatinib
    0378-2246Imatinib Mesylateimatinib
    42292-043Imatinib Mesylateimatinib
    42292-044Imatinib Mesylateimatinib
    51407-269Imatinib Mesylateimatinib
    51407-270Imatinib Mesylateimatinib
    65162-794Imatinib MesylateImatinib
    65162-795Imatinib MesylateImatinib
    68180-390IMATINIB MESYLATEIMATINIB
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.